The multiple functions of insulin-like growth factor 1 in kidney disease
Nefrología (English Edition) · 2025
DOI: 10.1016/j.nefroe.2025.501337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nefrología (English Edition), 2025. Verfasst von Juan Miguel Díaz Tocados und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vascular and Renal Translational Research Group, Biomedical Research Institute of Lleida (IRBLleida), Lleida, Spain; Cooperative Research Network Ori…. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Kidney Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sociedad Española de Nefrología, European Regional Development Fund, Secretaría de Estado de Investigacion, Desarrollo e Innovacion.
Abstract (Originalsprache)
Unilateral nephrectomy (Uni-Nx) produces compensatory hypertrophy of the remnant kidney. In this anabolic process, the upregulation of renal insulin-like growth factor 1 (IGF-1) plays a key role, which has inspired numerous studies considering the potential regenerative actions of the IGF-1 and the subsequent increase in the glomerular filtration rate. Thus, IGF-1 administration has shown to be able to induce renal hypertrophy, increase glomerular size and enhance glomerular filtration rate, without reaching glomerulosclerosis. Moreover, protein uptake also contributes to renal hypertrophy by increasing renal and circulating IGF-1 levels. In this respect, circulating IGF-1 concentration has been used as a marker of the nutritional status in end-stage CKD patients and has been associated with hormones that participate in the regulation of appetite. Moreover, IGF-1 regulate mineral metabolism, participating in phosphate resorption and calcitriol production by increasing 1-α-hydroxylase activity. Furthermore, IGF-1 is key for bone growth in pediatric patients, acting directly in chondrocytes, osteoblasts and, in a lesser manner, in osteoclasts. In addition, IGF-1 is an important inductor of erythroid proliferation, being able to maintain erythrocytic homeostasis in anephric patients. Nevertheless, the actions of the IGF-1 are attenuated in the context of renal disease, which may be promoted by the presence of inhibitory factors, such as the IGF binding proteins, and inability to trigger intracellular downstream signaling despite of normal IGF-1 receptor expression in cell surface. This review highlights the importance of the IGF-1 in the context of CKD and its potential contribution to renal and also systemic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vascular and Renal Translational Research Group, Biomedical Research Institute of Lleida (IRBLleida), Lleida, Spain; Cooperative Research Network Oriented Towards Health Outcomes (RICORS), Carlos III Health Institute (I…
- Vascular and Renal Translational Research Group, Biomedical Research Institute of Lleida (IRBLleida), Lleida, Spain.
Förderung
- Sociedad Española de Nefrología
- European Regional Development Fund
- Secretaría de Estado de Investigacion, Desarrollo e Innovacion
- Instituto de Salud Carlos III
Zitieren
APA
Díaz Tocados, J. M., Pérez Gómez, A., Diego Domínguez Coral, J., & Manuel Valdivielso, J. (2025). The multiple functions of insulin-like growth factor 1 in kidney disease. Nefrología (English Edition). https://doi.org/10.1016/j.nefroe.2025.501337
Vancouver
Díaz Tocados JM, Pérez Gómez A, Diego Domínguez Coral J, Manuel Valdivielso J. The multiple functions of insulin-like growth factor 1 in kidney disease. Nefrología (English Edition). 2025. doi:10.1016/j.nefroe.2025.501337
BibTeX
@article{DazTocados2025,
author = {Díaz Tocados, Juan Miguel and Pérez Gómez, Aurora and Diego Domínguez Coral, Juan and Manuel Valdivielso, José},
title = {The multiple functions of insulin-like growth factor 1 in kidney disease},
journal = {Nefrología (English Edition)},
year = {2025},
doi = {10.1016/j.nefroe.2025.501337}
}
EUVIMED